东阿阿胶 (000423)

Dong-E-E-Jiao Co., Ltd.

ASZ

Tags

New QFII HoldingsQFII Heavy PositionsCSI Central State-Owned Enterprises IndexAnalyst Recommended StocksBroker Heavy PositionsNorthbound Heavy PositionsBuyback PlansGuozheng Growth IndexCentral State-Owned Enterprises 100 IndexCCTV 50 IndexSmall Cap GrowthInvestment ClockEmerging Markets IndexTourism ConceptNew Private Equity HoldingsHigh-Performing StocksMargin Trading and Securities LendingNorthbound Connect Heavy PositionsNon-Cyclical StocksHigh-Dividend StocksHigh-Dividend Yield StocksShenzhen ConnectSZSE 300 IndexSZSE Value IndexSZSE Growth IndexCSFC HoldingsPharma & BiotechChinese Med. IISZSE Defensive 50 IndexStable Growth IndexConsumer Services IndexSZSE Medicine Equal Weight IndexBrand Engineering IndexSZSE Clock IndexShenzhen A-Share Pharmaceutical IndexSHS Dividend Growth Low Volatility IndexCSI All-share Pharmaceutical Sector IndexSZSE Emerging Industries IndexSZSE 1000 IndexSZSE 300 Return IndexCSSW Health IndexCSI 1000 Growth IndexLarge & Mid-cap IndexCNI 1000 IndexXingyin Wealth Management Balanced 300 IndexSZSE Performance IndexOrient Securities Value IndexState-owned Enterprises Belt and Road IndexChengtong Central Enterprises Dividend IndexShenzhen-Hong Kong Stock ConnectQFII HoldingsMSCIFTSE Russell ConceptHuijin ConceptShareholding Increase CommitmentLarge-cap Blue-chipExpected Profit/IncreaseFull Circulation SharesVenture CapitalPension Industry IndexSZSE Selected IndexSZSE Central Enterprises IndexCNI Culture IndexSZSE Composite IndexNew IndexSZSE Technology IndexCCTV Culture IndexEmerging Industries Composite IndexManufacturing IndexCSRC Central Enterprises Composite IndexSecurities Times Value 100 IndexSZSE Pharmaceutical IndexDividend Quality IndexCSI 800 IndexCS Pharmaceutical TI IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexCNI 300 IndexCCTV 500 IndexChina United Quality Growth IndexSZSE Component Pharmaceutical IndexPharmaceutical Sub-sector IndexChengtong Central Enterprises ESG IndexSZSE Low Volatility IndexCSI All-share Pharmaceutical IndexSZSE Pharmaceutical 50 IndexSZSE 300 Equal Weight IndexCSI Pharmaceutical IndexZhaoyang 100 IndexCSI 500 Equal Weight IndexCSI 800 Pharmaceutical IndexSZSE Component Index Equal WeightPharmaceutical & Health 100 IndexHigh Dividend Yield Strategy IndexCSI 700 IndexMid-small Cap IndexCSI 500 IndexCSI 500 IndexPharmaceutical 50 IndexCSI 500 Growth Innovation IndexPharmaceutical 50 Strategy IndexSZSE 200 Return IndexSZSE 200 IndexMid-cap Low Volatility IndexStructural Adjustment IndexESG 300 IndexCR New Momentum IndexJuchao Mid-cap IndexCSI 1000 Value IndexSZSE 500 IndexCSI 500 ESG IndexCSI 500 Growth Valuation IndexCSI 800 Cash Flow IndexCSI Cash Flow IndexStrategic Emerging Industries 100 IndexShandong

K-Line Chart

No K-line data available

Company NameDong-E-E-Jiao Co., Ltd.
Listing Date1996-07-29
Issue Price5.28RMB
Registered Capital64397.682410k RMB
Legal RepresentativeSun Jinni
Registered AddressNo. 78 Ejiao Street, Dong'e County, Shandong Province
IndustryTraditional Chinese Medicine II
Main BusinessProduction and operation of products including Chinese patent medicines, biopharmaceuticals, health foods, pharmaceutical excipients, medical devices, packaging and printing, etc.
Company ProfileThe company is affiliated with the central state-owned enterprise China Resources Group. Its predecessor was Shandong Dong-E-E-Jiao Factory, established in 1952. It was restructured from a state-owned enterprise into a joint-stock company in 1993 and was listed on the Shenzhen Stock Exchange in July 1996. Currently, the company is the largest producer of donkey-hide gelatin and related series products in China. It has over 4,800 employees, total assets of 13.87 billion yuan, and possesses 3 China Famous Trademarks, 2 confidential product varieties, and 8 protected product varieties. Its products are sold domestically and exported to regions including Hong Kong, Macao, Southeast Asia, Europe, and America.

Stock Details

1. Key Indicators

  • Total Shares(W): 64397.68
  • Circulating A-Shares(W): 64301.81
  • Earnings Per Share(RMB): 1.9781
  • Net Assets Per Share(RMB): 15.4476
  • Operating Revenue(W RMB): 476637.06
  • Total Profit(W RMB): 150297.21
  • Net Profit Attributable to Parent(W RMB): 127382.01
  • Net Profit Growth Rate(%): 10.58
  • Weighted Return on Equity(%): 12.1400
  • Operating Cash Flow Per Share(RMB): 2.0340
  • Undistributed Profit Per Share(RMB): 13.2831
  • Capital Reserve Per Share(RMB): 0.6022

2. Main Business

The main business covers:

  • Research, development, production, and sales of donkey-hide gelatin and related series products, as well as other Chinese patent medicines.
  • Industrial investment and equity investment.
  • Livestock breeding, acquisition, slaughtering, processing, and sales.
  • Planting, production, acquisition, processing, and sales of Chinese medicinal herbs.
  • Production, processing, and sales of health foods and general foods.
  • Production and sales of cosmetics (skin care products), health equipment, medical devices, small kitchenware, cleaning supplies, and household appliances.
  • Health consulting and services, tourism services, conference exhibition and reception services, and handicraft sales.

3. Company Basic Information

  • Company Name: Dong-E-E-Jiao Co., Ltd.
  • Listing Date: 1996-07-29
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 78 Ejiao Street, Dong'e County, Shandong Province, China
  • Website: www.dongeejiao.com
  • Company Profile: The company was established in February 1993 through the restructuring of the original Dong'e Ejiao Factory. Initially, its productive net assets were converted into 16.8 million state-owned shares, and 25 million employee shares were privately placed. After the initial public offering in July 1996, the total number of shares at the time of listing was 62.38 million. The 6.6 million internal employee shares, which occupied the quota, were listed and traded together with the public shares on July 29, 1996.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 China Resources Dong'e Ejiao Co., Ltd. General Legal Person 15135.17 23.54
2 China Resources Pharmaceutical Investment Co., Ltd. General Legal Person 6564.46 10.21
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 4152.30 6.46
4 CSI 500 Exchange Traded Open-End Index Securities Investment Fund Fund 657.84 1.02
5 Beijing Chengyang Investment Co., Ltd. - Chengyang No.1 Private Securities Investment Fund Private Securities Investment Fund 393.95 0.61
6 Bocom Schroders New Growth Hybrid Securities Investment Fund Fund 340.71 0.53
7 UBS Asset Management (Singapore) Ltd. - UBS (Lux) Investment SICAV QFII 328.64 0.51
8 China International Capital Corporation Limited Broker 312.64 0.49
9 ChinaAMC CSI Traditional Chinese Medicine ETF Fund 281.32 0.44
10 Harvest Taihe Hybrid Securities Investment Fund Fund 212.85 0.33

5. Concept Sectors

  • Rural Revitalization
  • Prepared Dishes
  • Tourism Concept
  • Margin Trading & Securities Lending
  • High-Performance Stock
  • QFII Heavy Holdings
  • Broker Heavy Holdings
  • High Dividend Yield Stock
  • Share Repurchase Plan
  • QFII New Entry
  • Northbound Heavy Holdings
  • Mainland-Hong Kong Stock Connect Heavy
  • Non-Cyclical Stock
  • High Dividend Payout Stock
  • Private Placement New Entry
  • SZSE Value
  • SZSE Component Index
  • Mid-Cap Growth
  • SZSE 300
  • SZSE Dividend
  • CNI Growth
  • SZSE Growth
  • CCTV 50
  • CSI Central SOEs
  • Investment Clock
  • Analyst Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information